In the context of active colitis, its upregulation likely represents the host’s attempt to counterbalance the overwhelming production of pro-inflammatory cytokines (e.g., TNF-α, IL-6) and to restrain overactive immune cells [51]. The gene discussed is IL6; the disease is colitis.